Research Analysts Offer Predictions for CVE:HIV Q3 Earnings

HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Equities research analysts at HC Wainwright decreased their Q3 2027 earnings estimates for shares of HIVE Blockchain Technologies in a research note issued on Wednesday, November 11th. HC Wainwright analyst M. Colonnese now forecasts that the company will post earnings per share of ($0.21) for the quarter, down from their prior forecast of ($0.13). HC Wainwright also issued estimates for HIVE Blockchain Technologies’ Q4 2027 earnings at ($0.16) EPS, Q1 2028 earnings at ($0.13) EPS, Q2 2028 earnings at ($0.11) EPS, Q3 2028 earnings at ($0.10) EPS, Q4 2028 earnings at ($0.11) EPS and FY2028 earnings at ($0.47) EPS.

Separately, Chardan Capital upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a report on Monday, July 27th. Two investment analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Buy”.

View Our Latest Report on HIV

HIVE Blockchain Technologies Stock Performance

HIVE Blockchain Technologies Ltd. is a technology company in the Application Software industry.

Recommended Stories

Earnings History and Estimates for HIVE Blockchain Technologies (CVE:HIV)

Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.